Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T19:58:24.222Z.
Calculation as of: 2026-10-06T19:58:24.222Z.
Quote observation: 2026-10-06T19:51:10.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2a0cb01cc31f7f7a1ab27ea5f4e27b2bab80fdffd2dde3b1d08905865647984d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
Paranovus Entertainment Technology Ltd.
Market Cap
$3.27M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.26M
EV/Sales Ratio
N/A
TTM Avg
46.50x
3Y Avg
481.93x
5Y Avg
1980.99x
Market Cap
$3.34M
EV/Sales Ratio
10.75x
TTM Avg
51.17x
3Y Avg
75.53x
5Y Avg
61.28x
Market Cap
$3.09M
EV/Sales Ratio
0.04x
TTM Avg
12.73x
3Y Avg
44.72x
5Y Avg
67.78x
Market Cap
$3.45M
EV/Sales Ratio
N/A
TTM Avg
141394.83x
3Y Avg
141394.83x
5Y Avg
141394.83x
Market Cap
$3.46M
EV/Sales Ratio
N/A
TTM Avg
5.13x
3Y Avg
110.83x
5Y Avg
110.83x
Market Cap
$3.01M
EV/Sales Ratio
N/A
TTM Avg
126.62x
3Y Avg
132.74x
5Y Avg
132.74x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Paranovus Entertainment Technology Ltd. (PAVS) | $3.27M | N/A | N/A | N/A | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.26M | N/A | 46.50x | 481.93x | 1980.99x |
| MBody AI Ltd. (MBAI)vs › | $3.21M | N/A | N/A | N/A | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.34M | 10.75x | 51.17x | 75.53x | 61.28x |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.09M | 0.04x | 12.73x | 44.72x | 67.78x |
| Mustang Bio, Inc. (MBIO)vs › | $3.45M | N/A | 141394.83x | 141394.83x | 141394.83x |
| Moolec Science S.A. (MLEC)vs › | $3.46M | N/A | 5.13x | 110.83x | 110.83x |
| Eocene Ltd. (EOCN)vs › | $3.50M | N/A | N/A | N/A | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.01M | N/A | 126.62x | 132.74x | 132.74x |
| Revelation Biosciences, Inc. (REVB)vs › | $2.93M | N/A | N/A | N/A | N/A |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
